UK Medical Cannabis
Investment Summit 2027
The senior closed forum for UK medical cannabis investors, family offices, private wealth owners, policymakers and global industry leaders.
Two days. One room. The verified investors, family offices, executives, clinicians, policymakers and global industry leaders defining the future of the UK medical cannabis market — convened in London for an educational, deal-focused and high-value two days of insight, dialogue, education and connection.
Where UK Medical Cannabis Investment Meets Education, Policy and Global Industry
The UK Medical Cannabis Investment Summit 2027 is the senior closed forum bringing together the investors, family office principals, private wealth owners, fund managers, executives, clinicians, researchers and policymakers shaping the future of medical cannabis in the United Kingdom.
The UK medical cannabis market has crossed 80,000 to 100,000 active patients, with over 40 licensed private clinics operating nationally and a market estimated at £300–500 million in value. Capital is flowing. Regulation is evolving. International operators are entering. And the most important decisions about the sector's next chapter are being made now.
This summit exists to convene the senior principals behind those decisions — in one room, in London, for two days in June 2027.
Designed to be both educational and deal-enabling, the Summit combines expert-led sessions on market intelligence, regulatory developments and investment strategy with structured networking, one-to-one meeting opportunities and a private environment where family offices, wealth owners and institutional investors can learn, connect and explore capital allocation with confidence.
Whether you are already invested in the UK medical cannabis sector or are a family office or private wealth owner seeking informed insight before making an allocation decision, this is the forum designed for you.
Educational & Insightful
Expert-led sessions on UK market intelligence, regulatory developments, investment strategy, clinical evidence and the global medical cannabis investment landscape — designed for investors at every stage of their medical cannabis journey.
Deal-Focused Networking
Structured one-to-one meetings, curated roundtables and private networking sessions connecting investors, family offices, operators and advisers in a confidential, senior environment.
Senior & Closed
Attendance is by application and verification only. The Summit is designed for principals — not intermediaries — ensuring every conversation in the room is between decision-makers.
A Room of Principals, Investors and Leaders
The UK Medical Cannabis Investment Summit 2027 is designed exclusively for senior decision-makers. Attendance is by application only.
Family Office Principals & CIOs
Single family office principals, CIOs and investment committees with direct mandates seeking informed exposure to the UK medical cannabis investment opportunity.
Private Wealth Owners
High and ultra-high net worth individuals and family wealth owners considering direct investment or co-investment allocations into the UK medical cannabis sector.
Institutional Investors & Fund Managers
Healthcare-focused fund managers, asset managers and institutional allocators with existing or prospective positions in medical cannabis, life sciences and healthcare.
Private Equity & Venture Capital
PE and VC professionals actively deploying or evaluating capital across UK medical cannabis operators, clinic networks, technology platforms and supply chain businesses.
Medical Cannabis Operators & Executives
Chief executives, founders and senior operators of licensed medical cannabis clinics, cultivation businesses, pharmacy networks and technology companies seeking investor dialogue.
Clinicians & Researchers
Senior clinicians, prescribers and researchers providing evidence-based insight into patient outcomes, clinical development and the evolving evidence base for medical cannabis.
Policymakers & Regulators
Government officials, MHRA representatives and policy advisers shaping the regulatory and legislative environment for medical cannabis in the United Kingdom.
Legal, Financial & Professional Advisers
Specialist solicitors, barristers, accountants, tax advisers and consultants active in medical cannabis transactions, licensing, compliance and investment structuring.
Two Days. Expert Insight. Private Dialogue. Real Connections.
The UK Medical Cannabis Investment Summit 2027 combines institutional-quality content with structured deal-enabling networking — designed for the senior professional who values both education and access.
Market Intelligence & Investment Briefings
Expert-led plenary sessions covering the current state of the UK medical cannabis market, capital flows, regulatory developments, clinical evidence and the international investment landscape. Designed to bring every attendee — from the newly curious family office to the experienced operator — to the same informed level.
Investor Roundtables
Small closed-group roundtable discussions on focused investment themes: family office allocation strategies, venture capital in medical cannabis, private equity deal structuring, clinical network investment and cross-border capital flows. Chatham House rules apply.
Policy, Regulation & The Road Ahead
Senior policy and regulatory sessions examining MHRA developments, NHS commissioning strategy, the conditions for market expansion and the legislative landscape shaping investment returns in 2027 and beyond.
One-to-One Meetings
Pre-scheduled private one-to-one meetings between investors, operators and advisers. A structured matchmaking process ensures every meeting is relevant, senior and purposeful.
Private Networking Reception
A closed invitation-only networking reception for all Summit attendees. The informal continuation of the day's conversations in a relaxed, premium setting.
Share Your Expertise With the UK's Senior Medical Cannabis Investment Community
The UK Medical Cannabis Investment Summit 2027 welcomes applications from senior investors, family office principals, clinicians, researchers, policy experts, regulators and industry leaders who can contribute meaningfully to the Summit's educational and investment-focused agenda.
We are particularly seeking speakers who can offer:
- Direct investor perspective on UK medical cannabis capital allocation
- Family office and private wealth viewpoints on the sector opportunity
- Clinical and research evidence on patient outcomes and market development
- Policy and regulatory insight from government, MHRA or NHS perspectives
- International investment experience in mature cannabis markets such as Germany, Australia and Canada
- Legal, financial and transactional expertise in medical cannabis investment structuring
Speaking at the UK Medical Cannabis Investment Summit 2027 places you in front of the UK's most senior audience of medical cannabis investors, family offices, private wealth owners and industry leaders.
To apply, complete the form. All applications are reviewed by the UKMC Group Ltd programme team. We will respond within five working days.
Position Your Organisation at the Heart of UK Medical Cannabis Investment
The UK Medical Cannabis Investment Summit 2027 is a two-day senior closed forum bringing together the UK's most active medical cannabis investors, family offices, private wealth owners, fund managers, clinicians, policymakers and industry leaders in London in June 2027. Our partnership packages place your organisation at the centre of every conversation across both days.
All packages are subject to availability and allocated on the basis of relevance and fit to the delegate audience. All prices are exclusive of VAT. To discuss any package contact us using the form below.
Speak or Moderate on a Panel
Your senior executive takes the stage for one of the Summit's main programme panel discussions across either Day One or Day Two — in front of the full room of verified medical cannabis investors, family offices, private wealth owners and industry leaders. Choose your role before the event: panellist or moderator. Named as Session Partner in the official programme throughout both days.
Deliver the Keynote
Open a Summit day or thematic session as the sole voice on stage. The room is set, the audience is seated and the subject is yours. Verified medical cannabis investors, family offices and industry leaders — no competing messages, no shared billing, no panel format. Available for Day One opening or Day Two opening.
Host a Private Roundtable
A closed room. Up to 18 verified investors, family office principals and industry leaders. Chatham House Rule. You set the agenda, open the discussion and chair the session. We select and brief the delegates and provide the full guest list in advance. Available across both Summit days. The most direct access to capital decision-makers available at the Summit.
Branded Showcase Presence
A dedicated branded presence in the Summit networking spaces across both days — the areas every delegate moves through throughout the two-day programme. Coffee breaks, lunches, receptions and networking all pass through here. Your brand is present at every one of them across Day One and Day Two.
Host the Drinks Reception
The evening drinks reception closes Day One with every delegate in the room. You open it. One partner welcome address, one room, every verified investor and industry leader in attendance. The highest-visibility single moment of the two-day Summit — and it belongs exclusively to you.
Host a Private Breakfast Briefing
Day Two opens early with a private session for up to 40 verified investors and family office principals before the main programme starts. You host the room, set the tone and open with facilitated introductions. Delegates arrive on the morning of Day Two having already read your brief.
Host a Private Lunch Briefing
While the main room breaks for lunch on either Summit day, up to 40 verified investors and family office principals sit down with you for a private hosted session. Closed door, curated guests, no outside noise. Available on Day One or Day Two. The most substantive hosted format available across both Summit days.
Lead the Dealflow Session
A curated closed session in which promising founders, operators and innovators from the UK medical cannabis sector pitch directly in front of verified investors and family office principals. You present as the session partner, shape the curation brief and own the stage throughout. The only session of its kind at the Summit — available on Day One or Day Two.
Keynote Plus
A keynote address combined with either a panel discussion or private roundtable — plus branded showcase presence across both Summit days. Stage presence, room presence and floor presence in a single package. For organisations that want to be seen, heard and in the room across both days.
The three headline tiers combine multiple formats into a single sustained presence across both Summit days. Each tier builds on the one below — with additional formats, communications and privileges at each level. These are the most comprehensive partnership positions available at the UK Medical Cannabis Investment Summit 2027.
Bronze — Headline Partnership
- Keynote address on Day One or Day Two
- Panel discussion or interactive roundtable
- Branded showcase presence throughout both Summit days
- Networking break sponsorship with partner welcome address to all delegates
- 2 delegate passes — full access both days
- Summit Brand Package — logo on all Summit materials including stage backdrop, lanyards, printed programme, official website, UKMC Group Ltd social media and pre-Summit subscriber communications to 20,000+ opted-in investors, family offices and industry professionals
Every major format at the two-day Summit covered — stage, room and floor — within a single partnership position.
Silver — Headline Partnership
- Exclusive sponsorship of the Day One evening drinks reception with partner welcome address
- Notepad sponsorship across both days
- Pre-Summit personalised introduction to all verified attendees before the Summit opens
- Featured in 2 UKMC Group Ltd subscriber communications reaching 20,000+ opted-in investors, family offices, private wealth owners and industry professionals ahead of the event
- 3 delegate passes — full access both days
- Priority brand placement across all Summit touchpoints across both days
Gold — Headline Partnership
- Lunch sponsorship across both Summit days with partner welcome address on each day
- Private dinner host for up to 40 guests on the evening of Day One
- Lanyard sponsorship across both days
- Premier brand placement at every Summit touchpoint across both days
- Pre-Summit personalised introduction to all verified attendees
- 3 dedicated UKMC Group Ltd social media posts over 3 weeks
- Featured in 2 subscriber communications reaching 20,000+ opted-in professionals
- First right of refusal on Gold partnership for the UK Medical Cannabis Investment Summit 2028
- 4 delegate passes — full access both days
The most significant partnership position available at the UK Medical Cannabis Investment Summit 2027.
Summit Brand Package includes: Logo placement on all Summit materials across both days — stage backdrop, lanyards, printed programme, official website, UKMC Group Ltd social media channels and pre-Summit subscriber communications to 20,000+ opted-in investors, family offices, private wealth owners and industry professionals.
Additional delegate passes for both days are available to all partners at a preferential rate. Contact us to discuss.
Attend the UK Medical Cannabis Investment Summit 2027
Two days of expert insight, educational sessions, private roundtables, structured networking and deal-enabling dialogue in London in June 2027. Places are strictly limited and subject to verification and approval by the UKMC Group Ltd events team.
SUMMIT DELEGATE PASS — BOTH DAYS
EARLY BIRD OPENFull two-day access to the UK Medical Cannabis Investment Summit 2027 — all plenary sessions, educational briefings, investor roundtables, networking breaks, lunches on both days and the Day One evening drinks reception.
- Full access — both Summit days
- All plenary sessions and educational briefings
- Investor roundtables and closed-door sessions
- Networking breaks and lunches — both days
- Day One evening drinks reception
- Printed Summit programme
- Pre-Summit delegate communications
- Early bird saving of £400 + VAT — book before 10 January 2027
Early bird rate of £595 + VAT available until 10 January 2027. Full rate of £995 + VAT applies from 11 January 2027. All registrations subject to verification and approval by the UKMC Group Ltd events team.
Complimentary Single Family Office Principal Pass
This pass is not for sale.
Complimentary attendance is strictly limited to verified single family office principals and CIOs principally managing the private wealth of one family — with assets under management of £200 million or above.
Not institutional allocators. Not multi-family offices. Not advisers. Not funds. Not service providers.
Eligibility is verified by the UKMC Group Ltd events team prior to confirmation. A limited number of Complimentary Single Family Office Principal Passes are available at the UK Medical Cannabis Investment Summit 2027.
If you are a single family office principal or CIO managing £200 million or above — apply now. Places are allocated on a first-verified basis and go quickly.
Not everyone who calls themselves a family office principal is one. Our verification process exists to make sure every person in the room is exactly who they say they are.
The Complimentary Single Family Office Principal Pass is strictly limited to verified single family office principals and CIOs managing the private wealth of one family with assets under management of £200 million or above. Institutional allocators, multi-family offices, advisers, funds and service providers are not eligible. Subject to verification and approval by the UKMC Group Ltd events team. UKMC Group Ltd reserves the right to decline any application without providing a reason.
Discuss a Partnership or Book Your Place
Complete the form and a member of the UKMC Group Ltd events team will respond within two business days with full package details, two-day programme information and availability.
All partnership packages are subject to availability and allocated on the basis of relevance and fit to the delegate audience. All prices are exclusive of VAT. Summit Delegate Pass: Early Bird £595 + VAT per person (book by 10 January 2027). Full rate £995 + VAT per person from 11 January 2027. Full two-day access. The UK Medical Cannabis Investment Summit 2027 is a two-day event organised by UKMC Group Ltd. Nothing communicated at or in connection with the Summit constitutes financial, investment or legal advice. Contact: info@ukmcgroup.co.uk
Apply to Attend the UK Medical Cannabis Investment Summit 2027
The UK Medical Cannabis Investment Summit 2027 is a closed, by-application event. Places are strictly limited to preserve the seniority and quality of the room.
Attendance is open to:
- Family office principals, CIOs and investment committees
- Private wealth owners and high net worth individuals
- Institutional investors and fund managers
- Private equity and venture capital professionals
- Medical cannabis operators and senior executives
- Clinicians, researchers and policy experts
- Legal, financial and professional advisers active in the sector
Attendance is not open to intermediaries, brokers or service providers without a direct investment mandate or operational role in the medical cannabis sector.
Ticket pricing will be confirmed in Q4 2026. Register your interest now to receive priority access, early bird pricing and advance programme information.
All registrations are subject to review and verification by the UKMC Group Ltd events team. We will be in touch within five working days of your registration.
Attendance is subject to verification and approval by the UKMC Group Ltd events team. Ticket pricing will be confirmed in Q4 2026. By registering you consent to being contacted about the UK Medical Cannabis Investment Summit 2027 and related UKMC Group Ltd events.
Organised by UKMC Group Ltd
The UK Medical Cannabis Investment Summit 2027 is organised by UKMC Group Ltd, a UK-based group operating across healthcare and life sciences media, events, patient services and investment intelligence.
UKMC Group Ltd operates UKMC Events, Healthcare Investor Magazine, UKMC Media and UKMC Lounges — bringing together a network of investors, family offices, clinicians, policymakers and industry leaders active across UK healthcare and medical cannabis.
For all enquiries contact: info@ukmcgroup.co.uk
UKMC Events
The events and summit division of UKMC Group Ltd — convening senior investors, family offices and industry leaders across UK healthcare and medical cannabis.
Healthcare Investor Magazine
Independent investment intelligence for investors, family offices and private wealth owners active across UK healthcare, life sciences and medical cannabis — published by UKMC Media.
UKMC Lounges
Professional membership spaces for verified UK medical cannabis patients — opening in central Norwich in Q1 2027.
Get In Touch
Speaker Enquiries
For speaking applications and programme enquiries